表紙
市場調査レポート

中国におけるポイントオブケア検査(POCT)市場

POCT Market in China 2014-2018

発行 TechNavio (Infiniti Research Ltd.) 商品コード 312482
出版日 ページ情報 英文 76 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。
Back to Top
中国におけるポイントオブケア検査(POCT)市場 POCT Market in China 2014-2018
出版日: 2014年09月10日 ページ情報: 英文 76 Pages
概要

ポイントオブケア検査(POCT)は、糖尿病、心疾患、肥満症といった生活習慣病の増加に伴い、普及し始めています。POCTは、患者のQOL(Ouality of Life:生活の質)の向上において、大きな役割を担っています。中国のPOCT市場は、2013年から2018年にかけて、20.69%のCAGRで拡大することが見込まれています。

当レポートでは、中国のポイントオブケア検査(POCT)市場の現状と将来予測を行っており、アプリケーション別、技術別の動向、市場の発展要因と課題、主要企業の分析などを提供しています。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 調査範囲

  • 市場概要
  • 主な製品

第4章 市場調査手法

  • 市場調査プロセス
  • 調査手法

第5章 イントロダクション

第6章 市場情勢

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第7章 アプリケーション別の市場区分

  • 血糖値検査
  • コレステロール検査
  • 感染症検査
  • 血中ガス検査
  • 心臓バイオマーカー検査
  • 妊娠検査

第8章 技術別の市場区分

  • 電気化学バイオセンサー
  • 光学バイオセンサー
  • 圧電バイオセンサー

第9章 購入基準

第10章 市場成長因子

第11章 成長因子とその影響

第12章 市場の課題

第13章 成長因子と課題の影響

第14章 市場動向

第15章 動向とその影響

第16章 ベンダー情勢

  • 競合シナリオ
    • 主なニュース
  • 市場シェア分析
  • その他の有力ベンダー
  • Abbott Laboratories
  • Bayer HealthCare
  • LifeScan
  • F. Hoffmann La Roche
目次
Product Code: IRTNTR4131

About POCT

POCT, also called near-patient testing, is performed outside a clinical laboratory. It helps in making fast clinical decisions, and hence in administrating appropriate treatments and medication. POCT is gaining popularity due to the increasing incidence and prevalence of lifestyle diseases such as diabetes, heart disease, and obesity. It is generally cost-effective and user-friendly. POCT devices are standardized to minimize errors during the diagnosis of patients. POCT plays a major role in improving patients' quality of life.

TechNavio's analysts forecast the POCT market in China to grow at a CAGR of 20.69 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the POCT market in China for the period 2014-2018. To calculate the market size, the report considers the revenue generated through the following applications of POCT:

  • Blood glucose testing
  • Cholesterol testing
  • Infectious disease testing
  • Blood gas testing
  • Cardiac biomarkers testing
  • Pregnancy testing
  • Others (such as cancer biomarker, electrolyte analyzers, blood coagulation testing, tumor marker, and urinalysis testing)

TechNavio's report, the POCT Market in China 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers China; it also covers the landscape of the POCT market in China and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Region

  • China

Key Vendors

  • Abbott Laboratories
  • Bayer HealthCare
  • F. Hoffmann-La Roche
  • LifeScan

Other Prominent Vendors

  • Bioptik Technology
  • Chongqing Haray International Business
  • Fudakang Ind'l
  • Guangzhou Maya Medical Equipment
  • Jiangxi Zhongchenda Industrial Investment
  • Nantong Voyage International Trade
  • Shenzhen Fitconn Technology
  • Shiny Health Import & Export
  • Sunrising Enterprise
  • Wuhan HNC Technology
  • Yuan Yu Bio-Tech

Market Driver

  • Technological Innovations

For a full, detailed list, view our report

Market Challenge

  • Advances in Technology

For a full, detailed list, view our report

Market Trend

  • Expanding Economy of China

For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be
  • What are the key market trends
  • What is driving this market
  • What are the challenges to market growth
  • Who are the key vendors in this market space
  • What are the market opportunities and threats faced by the key vendors
  • What are the strengths and weaknesses of the key vendors

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Application

  • 07.1. Blood Glucose Testing Market in China
    • 07.1.1. Market Size and Forecast
  • 07.2. Cholesterol Testing Market in China
    • 07.2.1. Market Size and Forecast
  • 07.3. Infectious Disease Testing Market in China
    • 07.3.1. Market Size and Forecast
  • 07.4. Blood Gas Testing Market in China
    • 07.4.1. Market Size and Forecast
  • 07.5. Cardiac Biomarkers Testing Market in China
    • 07.5.1. Market Size and Forecast
  • 07.6. Pregnancy Testing Market in China
    • 07.6.1. Market Size and Forecast

08. Market Segmentation by Technology

  • 08.1. Electrochemical Biosensors
  • 08.2. Optical Biosensors
  • 08.3. Piezoelectric Biosensors

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

  • 16.1. Competitive Scenario
    • 16.1.1. Key News
  • 16.2. Market Share Analysis 2013
  • 16.3. Other Prominent Vendors
  • 16.4. Abbott Laboratories
    • 16.4.1. Key Facts
    • 16.4.2. Business Overview
    • 16.4.3. Business Segmentation by Revenue 2012
    • 16.4.4. Business Segmentation by Revenue 2011 and 2012
    • 16.4.5. Geographical Segmentation by Revenue 2012
    • 16.4.6. Business Strategy
    • 16.4.7. Key Information
    • 16.4.8. SWOT Analysis
    • 16.4.9. Strengths
    • 16.4.10. Weakness
    • 16.4.11. Opportunities
    • 16.4.12. Threats
  • 16.5. Bayer HealthCare
    • 16.5.1. Key Facts
    • 16.5.2. Business Overview
    • 16.5.3. Business Segmentation by Revenue 2013
    • 16.5.4. Business Segmentation by Revenue 2012 and 2013
    • 16.5.5. Geographical Segmentation by Revenue 2013
    • 16.5.6. Business Strategy
    • 16.5.7. Recent Developments
    • 16.5.8. SWOT Analysis
    • 16.5.9. Strengths
    • 16.5.10. Weaknesses
    • 16.5.11. Opportunities
    • 16.5.12. Threats
  • 16.6. LifeScan
    • 16.6.1. Key Facts
    • 16.6.2. Business Overview
    • 16.6.3. Product Segmentation
    • 16.6.4. Geographical Segmentation by Revenue 2013
    • 16.6.5. Business Strategy
    • 16.6.6. Recent Developments
    • 16.6.7. SWOT Analysis
    • 16.6.8. Strengths
    • 16.6.9. Weaknesses
    • 16.6.10. Opportunities
    • 16.6.11. Threats
  • 16.7. F. Hoffmann La Roche
    • 16.7.1. Key Facts
    • 16.7.2. Business Overview
    • 16.7.3. Business Segmentation by Revenue 2013
    • 16.7.4. Business Segmentation by Revenue 2012 and 2013
    • 16.7.5. Sales by Geography 2013
    • 16.7.6. Business Strategy
    • 16.7.7. Recent Developments
    • 16.7.8. SWOT Analysis
    • 16.7.9. Strengths
    • 16.7.10. Weaknesses
    • 16.7.11. Opportunities
    • 16.7.12. Threats

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: POCT market in China 2013-2018 (US$ million)
  • Exhibit 3: POCT Market in China Segmentation by Application
  • Exhibit 4: POCT Market in China Segmentation by Application 2013
  • Exhibit 5: Blood Glucose Testing Market in China 2013-2018 (US$ million)
  • Exhibit 6: Cholesterol Testing Market in China 2013-2018 (US$ million)
  • Exhibit 7: Infectious Disease Testing Market in China 2013-2018 (US$ million)
  • Exhibit 8: Blood Gas Testing Market in China 2013-2018 (US$ million)
  • Exhibit 9: Cardiac Biomarkers Testing Market in China 2013-2018 (US$ million)
  • Exhibit 10: Pregnancy Testing Market in China 2013-2018 (US$ million)
  • Exhibit 11: POCT market in China Segmentation by Application 2013-2018
  • Exhibit 12: POCT Market Segmentation by Technology in China
  • Exhibit 13: Abbott Laboratories: Business Segmentation by Revenue 2012
  • Exhibit 14: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 (US$ million)
  • Exhibit 15: Abbott Laboratories: Geographical Segmentation by Revenue 2012
  • Exhibit 16: Bayer Healthcare: Business Segmentation by Revenue 2013
  • Exhibit 17: Bayer Healthcare: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 18: Bayer Healthcare: Geographical Segmentation by Revenue 2013
  • Exhibit 19: LifeScan: Product Segmentation 2013
  • Exhibit 20: LifeScan: Geographical Segmentation by Revenue 2013
  • Exhibit 21: F. Hoffmann-La Roche: Business Segmentation by Revenue 2013
  • Exhibit 22: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
  • Exhibit 23: F. Hoffmann-La Roche: Sales of Pharmaceuticals Division by Geography 2013
  • Exhibit 24: F. Hoffmann-La Roche: Sales of Diagnostics Division by Geography 2013
Back to Top